Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis
Crossref DOI link: https://doi.org/10.1186/s12936-015-0881-2
Published Online: 2015-09-17
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gray, Alyson M.
Arguin, Paul M.
Hamed, Kamal https://orcid.org/0000-0003-1896-9736
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (US)
